MISHC is one of 3 quality consortia under the umbrella of the Blue Cross Blue Shield of Michigan Cardiovascular Consortium, or BMC2.
News
From Our Blog
MAQI2 Works To Decrease Bleeding Risk In Patients On Warfarin And Aspirin After PCI And TAVR
The Michigan Anticoagulation Quality Improvement Initiative (MAQI2) found that patients taking warfarin in combination with aspirin had twice the rate of bleeding with no clear clinical benefit, similar to other published literature.
Spotlight On MyMichigan Health: Reducing Heart Failure Admissions After TAVR Procedures
MyMichigan Health experienced an increase in post-TAVR heart failure admissions in 2019 and 2020.
Site Spotlight - Trinity Health Ann Arbor
The Structural Heart Team at Trinity Health Ann Arbor realized that their pre-procedural baseline and 30-day KCCQ questionnaire documentation compliance was below the consortium’s average.